Westport Resources Management’s AstraZeneca AZN Stock Holding History

Westport Resources Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$5K	Hold	73	–	–	﹤0.01%	499
2016 Q2	$4K	Hold	73	–	–	﹤0.01%	649
2016 Q1	$4K	Buy	+73	New	+$4.39K	﹤0.01%	654
2014 Q1	–	Sell	-225	Closed	-$13K	–	1095
2013 Q4	$13K	Hold	225	–	–	﹤0.01%	852
2013 Q3	$12K	Hold	225	–	–	﹤0.01%	847
2013 Q2	$11K	Buy	+225	New	+$11.5K	﹤0.01%	840

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Westport Resources Management's AZN Position: Q3 2016 in Review

Westport Resources Management held its AstraZeneca (AZN) position steady in Q3 2016 at 73 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #499.

Westport Resources Management first reported a position in AZN in Q2 2013 and has held it in 6 quarters since. The position peaked at $13K in Q4 2013. 449 funds tracked by Wall St. Rank hold AZN as of Q3 2016.

Westport Resources Management held 73 shares of AstraZeneca worth $5K as of Q3 2016.
Westport Resources Management left its AstraZeneca share count unchanged in Q3 2016.
AstraZeneca made up ﹤0.01% of Westport Resources Management's portfolio in Q3 2016, its #499 holding.
Westport Resources Management first reported a position in AstraZeneca in Q2 2013 and has held it in 6 quarters since.
Westport Resources Management's AstraZeneca position peaked at $13K in Q4 2013.
449 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2016.

Based on Westport Resources Management's 13F filing for Q3 2016, filed 14 Nov 2016.